ADMA insider buying and SEC filings, explained
Adma Biologics, Inc. · CIK 1368514
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- R&R ACQUISITION VI, INC
Insider activity in the last 12 months
Bought
$468K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$1.4M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 27, 2026 | Open-market purchase | Jerrold B Grossman (Director) bought 6,400 shares at $7.91 ($51K) in an open-market purchase. Holdings up 1% to 520,284 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 28, 2026 |
| May 12, 2026 | Open-market purchase | Jerrold B Grossman (Director) bought 12,500 shares at $8.01 ($100K) in an open-market purchase. Holdings up 2% to 513,884 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 14, 2026 |
| May 11, 2026 | Open-market purchase | Jerrold B Grossman (Director) bought 12,500 shares at $8.01 ($100K) in an open-market purchase. Holdings up 3% to 501,384 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 12, 2026 |
| Mar 16, 2026 | Planned (10b5-1) | Adam S Grossman (CEO and Director) sold 21,000 shares at $15.16 ($318K), marked as a 10b5-1 plan trade. Holdings down 1% to 2,112,777 shares. | SEC filing Filed Mar 17, 2026 |
| Mar 5–6, 2026 | Open-market purchase | Steve Elms (Director) bought 14,000 shares indirectly between Mar 5 and Mar 6 at about $15.53 ($217K) in an open-market purchase. Indirect holdings up 1% to 2,045,730 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Feb 17, 2026 | Planned (10b5-1) | Adam S Grossman (CEO and Director) sold 21,000 shares at $16.08 ($338K), marked as a 10b5-1 plan trade. Holdings down 1% to 2,284,379 shares. | SEC filing Filed Feb 17, 2026 |
| Dec 15, 2025 | Planned (10b5-1) | Adam S Grossman (CEO and Director) sold 21,000 shares at $19.79 ($416K), marked as a 10b5-1 plan trade. Holdings down 1% to 2,007,850 shares. | SEC filing Filed Dec 16, 2025 |
| Nov 19, 2025 | Planned (10b5-1) | Adam S Grossman (CEO and Director) sold 21,000 shares at $16.00 ($336K), marked as a 10b5-1 plan trade. Holdings down 1% to 2,013,850 shares. | SEC filing Filed Nov 21, 2025 |
23 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ADMA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.